Journal of Cardiac Failure
@jcardfail.bsky.social
The official journal of @hfsa.bsky.social for original peer-reviewed research & reviews.
Co-EIC:
@robmentz.bsky.social &
@dranulala.bsky.social
https://linktr.ee/jcardfail
Co-EIC:
@robmentz.bsky.social &
@dranulala.bsky.social
https://linktr.ee/jcardfail
🚨 New Science alert! In this 🔥 article, the authors used the AHA's GWTG HF registry to show that there is significant undertesting & underdiagnosis of ATTR-CM among pts hospitalized for HF, with substantial hospital-level variation across US hospitals.
🔗 http://bit.ly/4hgFGXC
🔗 http://bit.ly/4hgFGXC
November 14, 2025 at 3:17 PM
🚨 New Science alert! In this 🔥 article, the authors used the AHA's GWTG HF registry to show that there is significant undertesting & underdiagnosis of ATTR-CM among pts hospitalized for HF, with substantial hospital-level variation across US hospitals.
🔗 http://bit.ly/4hgFGXC
🔗 http://bit.ly/4hgFGXC
Hemodynamics in focus. 🔍
Join Dr. Anu Lala for the Hemodynamics Focus issue of the Journal of Cardiac Failure, exploring all aspects of hemodynamics in heart failure.
Stay Curious and Connected - watch the full video here
🎥 https://youtu.be/dUBnApXqqr8
#JCF #Hemodynamics
Join Dr. Anu Lala for the Hemodynamics Focus issue of the Journal of Cardiac Failure, exploring all aspects of hemodynamics in heart failure.
Stay Curious and Connected - watch the full video here
🎥 https://youtu.be/dUBnApXqqr8
#JCF #Hemodynamics
November 13, 2025 at 4:52 PM
Hemodynamics in focus. 🔍
Join Dr. Anu Lala for the Hemodynamics Focus issue of the Journal of Cardiac Failure, exploring all aspects of hemodynamics in heart failure.
Stay Curious and Connected - watch the full video here
🎥 https://youtu.be/dUBnApXqqr8
#JCF #Hemodynamics
Join Dr. Anu Lala for the Hemodynamics Focus issue of the Journal of Cardiac Failure, exploring all aspects of hemodynamics in heart failure.
Stay Curious and Connected - watch the full video here
🎥 https://youtu.be/dUBnApXqqr8
#JCF #Hemodynamics
Could studies of remote monitoring be showing inconsistent impact on outcomes because of clinical workflows? This study sought to look at this very question!
What did they find? Clinical workflows were reported inconsistently and infrequently.
Read more ⬇️
🔗 bit.ly/48ZDGk7
What did they find? Clinical workflows were reported inconsistently and infrequently.
Read more ⬇️
🔗 bit.ly/48ZDGk7
November 12, 2025 at 4:07 PM
Could studies of remote monitoring be showing inconsistent impact on outcomes because of clinical workflows? This study sought to look at this very question!
What did they find? Clinical workflows were reported inconsistently and infrequently.
Read more ⬇️
🔗 bit.ly/48ZDGk7
What did they find? Clinical workflows were reported inconsistently and infrequently.
Read more ⬇️
🔗 bit.ly/48ZDGk7
📝 Don’t miss it - JCF’s Special Focus Issue on Hemodynamics is here!
Explore groundbreaking studies and expert perspectives. 🫀
👉 Read now: https://onlinejcf.com/current
Explore groundbreaking studies and expert perspectives. 🫀
👉 Read now: https://onlinejcf.com/current
November 11, 2025 at 4:42 PM
📝 Don’t miss it - JCF’s Special Focus Issue on Hemodynamics is here!
Explore groundbreaking studies and expert perspectives. 🫀
👉 Read now: https://onlinejcf.com/current
Explore groundbreaking studies and expert perspectives. 🫀
👉 Read now: https://onlinejcf.com/current
New Science 🚨!
Check out this visual roundup of findings from recent JCF publications—insights into disease markers and outcomes in 🫀 #FunctionNotFailure.
Learn more: links in our bio!
#JCF #Cardiology #HeartFailure
Check out this visual roundup of findings from recent JCF publications—insights into disease markers and outcomes in 🫀 #FunctionNotFailure.
Learn more: links in our bio!
#JCF #Cardiology #HeartFailure
November 11, 2025 at 4:12 PM
New Science 🚨!
Check out this visual roundup of findings from recent JCF publications—insights into disease markers and outcomes in 🫀 #FunctionNotFailure.
Learn more: links in our bio!
#JCF #Cardiology #HeartFailure
Check out this visual roundup of findings from recent JCF publications—insights into disease markers and outcomes in 🫀 #FunctionNotFailure.
Learn more: links in our bio!
#JCF #Cardiology #HeartFailure
#AHA2025 SimPub 🚨!
Using CDC WONDER data, this study found that amyloidosis-related mortality has doubled in the 🇺🇸 over the past 20 ys — with disparities by sex, age, race/ethnicity & region. Highlights the need for 🩺early diagnosis & equitable care.💜
🔗 bit.ly/3LS1ay3
Using CDC WONDER data, this study found that amyloidosis-related mortality has doubled in the 🇺🇸 over the past 20 ys — with disparities by sex, age, race/ethnicity & region. Highlights the need for 🩺early diagnosis & equitable care.💜
🔗 bit.ly/3LS1ay3
November 9, 2025 at 1:53 PM
#AHA2025 SimPub 🚨!
Using CDC WONDER data, this study found that amyloidosis-related mortality has doubled in the 🇺🇸 over the past 20 ys — with disparities by sex, age, race/ethnicity & region. Highlights the need for 🩺early diagnosis & equitable care.💜
🔗 bit.ly/3LS1ay3
Using CDC WONDER data, this study found that amyloidosis-related mortality has doubled in the 🇺🇸 over the past 20 ys — with disparities by sex, age, race/ethnicity & region. Highlights the need for 🩺early diagnosis & equitable care.💜
🔗 bit.ly/3LS1ay3
#AHA2025 SimPub 🚨!
Using GWTG registry data, this study found that hospitalized HF patients with ATTR-CM had 📈 higher HF readmission risk & 💵 greater costs — but no significant difference in 🏥 in-hospital or post-discharge mortality.
🔗 bit.ly/4qQxcdR
Using GWTG registry data, this study found that hospitalized HF patients with ATTR-CM had 📈 higher HF readmission risk & 💵 greater costs — but no significant difference in 🏥 in-hospital or post-discharge mortality.
🔗 bit.ly/4qQxcdR
November 8, 2025 at 4:23 PM
#AHA2025 SimPub 🚨!
Using GWTG registry data, this study found that hospitalized HF patients with ATTR-CM had 📈 higher HF readmission risk & 💵 greater costs — but no significant difference in 🏥 in-hospital or post-discharge mortality.
🔗 bit.ly/4qQxcdR
Using GWTG registry data, this study found that hospitalized HF patients with ATTR-CM had 📈 higher HF readmission risk & 💵 greater costs — but no significant difference in 🏥 in-hospital or post-discharge mortality.
🔗 bit.ly/4qQxcdR
#AHA2025 SimPub 🚨!
Hospital at Home (HaH) offers inpatient-level care at home. In this nationwide HF study, nearly ½ of hospitalizations were HaH-eligible 🏥➡️🏡 — with lower in-hospital mortality & shorter stays.
A promising future for #HeartFailure care! 💪❤️
🔗 bit.ly/4809x3g
Hospital at Home (HaH) offers inpatient-level care at home. In this nationwide HF study, nearly ½ of hospitalizations were HaH-eligible 🏥➡️🏡 — with lower in-hospital mortality & shorter stays.
A promising future for #HeartFailure care! 💪❤️
🔗 bit.ly/4809x3g
November 7, 2025 at 7:37 PM
#AHA2025 SimPub 🚨!
Hospital at Home (HaH) offers inpatient-level care at home. In this nationwide HF study, nearly ½ of hospitalizations were HaH-eligible 🏥➡️🏡 — with lower in-hospital mortality & shorter stays.
A promising future for #HeartFailure care! 💪❤️
🔗 bit.ly/4809x3g
Hospital at Home (HaH) offers inpatient-level care at home. In this nationwide HF study, nearly ½ of hospitalizations were HaH-eligible 🏥➡️🏡 — with lower in-hospital mortality & shorter stays.
A promising future for #HeartFailure care! 💪❤️
🔗 bit.ly/4809x3g
🚨 #AHA SimPub Alert! 🧪
POLY-HF will deliver the first randomized evidence on polypill effectiveness for biologic & clinical outcomes in HFrEF among underrepresented groups. ❤️🩹
It enrolled a diverse, socioeconomically-disadvantaged population with ⏬ 💊 adherence.
🔗 bit.ly/4nNRLFg
POLY-HF will deliver the first randomized evidence on polypill effectiveness for biologic & clinical outcomes in HFrEF among underrepresented groups. ❤️🩹
It enrolled a diverse, socioeconomically-disadvantaged population with ⏬ 💊 adherence.
🔗 bit.ly/4nNRLFg
November 7, 2025 at 6:57 PM
🚨 #AHA SimPub Alert! 🧪
POLY-HF will deliver the first randomized evidence on polypill effectiveness for biologic & clinical outcomes in HFrEF among underrepresented groups. ❤️🩹
It enrolled a diverse, socioeconomically-disadvantaged population with ⏬ 💊 adherence.
🔗 bit.ly/4nNRLFg
POLY-HF will deliver the first randomized evidence on polypill effectiveness for biologic & clinical outcomes in HFrEF among underrepresented groups. ❤️🩹
It enrolled a diverse, socioeconomically-disadvantaged population with ⏬ 💊 adherence.
🔗 bit.ly/4nNRLFg
Also, don’t miss the accompanying editorial, which analyzes the article and advocates for the integration of dietary assessment & counseling in routine CV care.
The daily decisions our patients make at the grocery store, restaurants, and at home matter!
🔗 bit.ly/4nRhJsn
The daily decisions our patients make at the grocery store, restaurants, and at home matter!
🔗 bit.ly/4nRhJsn
November 6, 2025 at 4:06 PM
Also, don’t miss the accompanying editorial, which analyzes the article and advocates for the integration of dietary assessment & counseling in routine CV care.
The daily decisions our patients make at the grocery store, restaurants, and at home matter!
🔗 bit.ly/4nRhJsn
The daily decisions our patients make at the grocery store, restaurants, and at home matter!
🔗 bit.ly/4nRhJsn
🚨Can diet influence risk of HF?
📌Analysis of 17,975 pts in the REGARDS cohort, median follow-up 11.1 y
📌Dietary Inflammatory Score (DIS)= tool to measure inflammatory potential of diet
📌Pro-inflammatory diets (highest DIS quartile) ⬆️ risk of incident HF
🔗 bit.ly/43dDnOZ
📌Analysis of 17,975 pts in the REGARDS cohort, median follow-up 11.1 y
📌Dietary Inflammatory Score (DIS)= tool to measure inflammatory potential of diet
📌Pro-inflammatory diets (highest DIS quartile) ⬆️ risk of incident HF
🔗 bit.ly/43dDnOZ
November 6, 2025 at 4:05 PM
🚨Can diet influence risk of HF?
📌Analysis of 17,975 pts in the REGARDS cohort, median follow-up 11.1 y
📌Dietary Inflammatory Score (DIS)= tool to measure inflammatory potential of diet
📌Pro-inflammatory diets (highest DIS quartile) ⬆️ risk of incident HF
🔗 bit.ly/43dDnOZ
📌Analysis of 17,975 pts in the REGARDS cohort, median follow-up 11.1 y
📌Dietary Inflammatory Score (DIS)= tool to measure inflammatory potential of diet
📌Pro-inflammatory diets (highest DIS quartile) ⬆️ risk of incident HF
🔗 bit.ly/43dDnOZ
A snapshot of progress in 🫀 #FunctionNotFailure science. This video rounds up some of the studies from our 🔥 August issue ... your guide to what’s moving the field forward.
Dive deeper - link in bio!
Dive deeper - link in bio!
November 5, 2025 at 3:38 PM
A snapshot of progress in 🫀 #FunctionNotFailure science. This video rounds up some of the studies from our 🔥 August issue ... your guide to what’s moving the field forward.
Dive deeper - link in bio!
Dive deeper - link in bio!
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Advance the field. Get published early 2026.
Categories & Topics: http://bit.ly/46gZVRq
📆 Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Cardiomyopathy #AcademicMedicine
Share your insights. Advance the field. Get published early 2026.
Categories & Topics: http://bit.ly/46gZVRq
📆 Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Cardiomyopathy #AcademicMedicine
October 31, 2025 at 2:17 PM
Focus Issue: Infiltrative & Inflammatory Cardiomyopathies
Share your insights. Advance the field. Get published early 2026.
Categories & Topics: http://bit.ly/46gZVRq
📆 Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Cardiomyopathy #AcademicMedicine
Share your insights. Advance the field. Get published early 2026.
Categories & Topics: http://bit.ly/46gZVRq
📆 Deadline: Dec. 8, 2025
#CardioTwitter #CardiologyResearch #CallForPapers #Cardiomyopathy #AcademicMedicine
ICYMI! New science! Fresh insights! JCF brings together groundbreaking work across the field of 🫀#FunctionNotFailure—exploring metabolism, pharmacologic innovation & hemodynamic discovery.
Check out these articles from our August issue and so much more!
📖link in bio!
#HeartFailure #Cardiology #JCF
Check out these articles from our August issue and so much more!
📖link in bio!
#HeartFailure #Cardiology #JCF
October 29, 2025 at 2:10 PM
ICYMI! New science! Fresh insights! JCF brings together groundbreaking work across the field of 🫀#FunctionNotFailure—exploring metabolism, pharmacologic innovation & hemodynamic discovery.
Check out these articles from our August issue and so much more!
📖link in bio!
#HeartFailure #Cardiology #JCF
Check out these articles from our August issue and so much more!
📖link in bio!
#HeartFailure #Cardiology #JCF
🚨 JCF's October Issue is here!
Explore new research and insights shaping the future of heart failure care in #JCF 🫀
🔗 onlinejcf.com/current
#HeartFailure #Cardiology
Explore new research and insights shaping the future of heart failure care in #JCF 🫀
🔗 onlinejcf.com/current
#HeartFailure #Cardiology
October 14, 2025 at 2:23 PM
🚨 JCF's October Issue is here!
Explore new research and insights shaping the future of heart failure care in #JCF 🫀
🔗 onlinejcf.com/current
#HeartFailure #Cardiology
Explore new research and insights shaping the future of heart failure care in #JCF 🫀
🔗 onlinejcf.com/current
#HeartFailure #Cardiology
Now accepting submissions for an issue on Infiltrative & Inflammatory Cardiomyopathies, publishing in Winter 2026.
Led by Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce, this issue will spotlight cutting-edge research into these evolving conditions.
Learn more: http://bit.ly/46gZVRq
📆 Due: Dec. 8
Led by Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce, this issue will spotlight cutting-edge research into these evolving conditions.
Learn more: http://bit.ly/46gZVRq
📆 Due: Dec. 8
October 7, 2025 at 2:27 PM
Now accepting submissions for an issue on Infiltrative & Inflammatory Cardiomyopathies, publishing in Winter 2026.
Led by Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce, this issue will spotlight cutting-edge research into these evolving conditions.
Learn more: http://bit.ly/46gZVRq
📆 Due: Dec. 8
Led by Drs. Nisha Gilotra, Mat Maurer, and Emer Joyce, this issue will spotlight cutting-edge research into these evolving conditions.
Learn more: http://bit.ly/46gZVRq
📆 Due: Dec. 8
🚨Our final #HFSA2025 Simpub! In this 🔥ECT Spotlight, @vbluml describes the critical distinction between native 🫀 survival, remission & recovery in CS, underscoring the implications of precise terminology for clinical care, research, and systems of care.
🔗 http://bit.ly/4mGN67A
🔗 http://bit.ly/4mGN67A
September 28, 2025 at 11:05 PM
🚨Our final #HFSA2025 Simpub! In this 🔥ECT Spotlight, @vbluml describes the critical distinction between native 🫀 survival, remission & recovery in CS, underscoring the implications of precise terminology for clinical care, research, and systems of care.
🔗 http://bit.ly/4mGN67A
🔗 http://bit.ly/4mGN67A
Optimizing Pre-to-Post Discharge Transition of Care in Patients Hospitalized for Heart Failure - Part 3 of the International Expert Opinion Series on Acute Heart Failure Management ➡️ bit.ly/4mK7eFR
September 28, 2025 at 10:39 PM
Optimizing Pre-to-Post Discharge Transition of Care in Patients Hospitalized for Heart Failure - Part 3 of the International Expert Opinion Series on Acute Heart Failure Management ➡️ bit.ly/4mK7eFR
The Role of a Future Heart Failure Cardiologist in Expanding Access to Transplantation ➡️ bit.ly/4mDlLTu
September 28, 2025 at 10:39 PM
The Role of a Future Heart Failure Cardiologist in Expanding Access to Transplantation ➡️ bit.ly/4mDlLTu
Building and Growing a Multidisciplinary Program as Early-Career Faculty: Lessons Learned and Practical Strategies ➡️ bit.ly/46YrdM9
September 28, 2025 at 10:39 PM
Building and Growing a Multidisciplinary Program as Early-Career Faculty: Lessons Learned and Practical Strategies ➡️ bit.ly/46YrdM9
Intravenous Ferric Carboxymaltose in Ischemic Versus Non-Ischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2 ➡️ bit.ly/4mDlFv6
September 28, 2025 at 10:39 PM
Intravenous Ferric Carboxymaltose in Ischemic Versus Non-Ischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2 ➡️ bit.ly/4mDlFv6
As the @hfsa.bsky.social Annual Scientific Meeting 2025 comes to a close, here are the final #HFSA2025 SimPubs, out now in the Journal of Cardiac Failure. 🚨
🧵👇
🧵👇
September 28, 2025 at 10:39 PM
As the @hfsa.bsky.social Annual Scientific Meeting 2025 comes to a close, here are the final #HFSA2025 SimPubs, out now in the Journal of Cardiac Failure. 🚨
🧵👇
🧵👇
Expanded Results from a Dedicated Guideline-Directed Medical Therapy Clinic ➡️ bit.ly/4gUajBW
September 28, 2025 at 9:26 PM
Expanded Results from a Dedicated Guideline-Directed Medical Therapy Clinic ➡️ bit.ly/4gUajBW
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM ➡️ bit.ly/42f0oRc
September 28, 2025 at 9:26 PM
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM ➡️ bit.ly/42f0oRc
Derivation of a Personalized Congestion Score Using a Chronic Implantable Inferior Vena Cava Management System in Heart Failure: An Analysis from the FUTURE-HF Trial Portfolio ➡️ bit.ly/4nqv3n7
September 28, 2025 at 9:26 PM
Derivation of a Personalized Congestion Score Using a Chronic Implantable Inferior Vena Cava Management System in Heart Failure: An Analysis from the FUTURE-HF Trial Portfolio ➡️ bit.ly/4nqv3n7